Clinical trials recruiting for Oligometastatic Prostate Cancer (OMPC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AAA617 | 1 |
| Anti-PD-1 monoclonal antibody | 1 |
| Stereotactic body radiotherapy (SBRT) | 1 |
| gallium (68Ga) gozetotide (25μg) | 1 |
| pTVG-HP DNA vaccine | 1 |
| piflufolastat (18F) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Iowa | 1 |
| Kansas | 1 |
| Louisiana | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)
- Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Related conditions
Trials recruiting for Oligometastatic Prostate Cancer (OMPC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Oligometastatic Prostate Cancer (OMPC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.